​

Quest Diagnostics (DGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DGX Stock Forecast

Quest Diagnostics (DGX) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $256.17, with a high of $262.00 and a low of $245.00. This represents a 5.18% increase from the last price of $243.55.

$170 $189 $208 $227 $246 $265 High: $262 Avg: $256.17 Low: $245 Last Closed Price: $243.55

DGX Stock Rating

Quest Diagnostics stock's rating consensus is Hold, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (38.24%), 18 Hold (52.94%), 3 Sell (8.82%), and 0 Strong Sell (0.00%).

Hold
Total 34 0 3 18 13 Strong Sell Sell Hold Buy Strong Buy

DGX Price Target Upside V Benchmarks

TypeNameUpside
StockQuest Diagnostics5.18%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks1.69%

Price Target Trends

1M3M12M
# Anlaysts31022
Avg Price Target$257.33$251.90$234.05
Last Closing Price$243.55$243.55$243.55
Upside/Downside5.66%3.43%-3.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26277-117
Sep, 26277-117
Aug, 26277-117
Jul, 26278-118
Jun, 26279--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2026Eric ColdwellRobert W. Baird$262.00$243.557.58%7.58%
Oct 19, 2026UBS$250.00$234.036.82%2.65%
Oct 07, 2026Luke SergottBarclays$260.00$228.4613.81%6.75%
Sep 21, 2026Truist Financial$260.00$246.485.49%6.75%
Sep 08, 2026UBS$245.00$235.584.00%0.60%
Jul 29, 2026Argus Research$260.00$235.3510.47%6.75%
Jul 24, 2026Kevin CaliendoUBS$232.00$231.300.30%-4.74%
Jul 24, 2026Robert W. Baird$255.00$227.9011.89%4.70%
Jul 23, 2026Barclays$250.00$227.909.70%2.65%
Jul 23, 2026Jefferies$245.00$227.907.50%0.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 19, 2026UBSNeutralNeutralhold
Oct 07, 2026BarclaysOverweightOverweighthold
Sep 08, 2026UBSNeutralNeutralhold
Jul 24, 2026UBSNeutralNeutralhold
Jul 23, 2026BarclaysOverweightOverweighthold
Jul 23, 2026JefferiesBuyBuyhold
Apr 21, 2026JefferiesBuyBuyhold
Feb 11, 2026UBSNeutralNeutralhold
Feb 11, 2026CitigroupNeutralNeutralhold
Feb 10, 2026JefferiesBuyBuyhold

Financial Forecast

EPS Forecast

$7 $8 $9 $10 $11 $12 $13 $14 $15 $16 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.90$8.12$7.59$7.80$8.87---
Avg Forecast$14.12$9.85$8.71$8.90$9.73$10.51$11.56$12.71
High Forecast$14.81$10.03$8.75$8.93$9.77$12.37$12.45$13.00
Low Forecast$13.49$9.53$8.68$8.87$9.70$9.86$10.67$12.13
Surprise %12.61%-17.56%-12.86%-12.36%-8.84%---

Revenue Forecast

$9B $10B $10B $11B $12B $13B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.79B$9.88B$9.25B$9.87B$11.04B---
Avg Forecast$10.74B$9.83B$9.22B$9.83B$10.71B$11.13B$11.68B$12.06B
High Forecast$11.15B$9.97B$9.24B$9.84B$10.84B$11.17B$11.88B$12.27B
Low Forecast$10.37B$9.58B$9.20B$9.81B$10.50B$11.10B$11.49B$11.63B
Surprise %0.44%0.54%0.39%0.43%3.06%---

Net Income Forecast

$500M $900M $1B $2B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.00B$946.00M$854.00M$871.00M$992.00M---
Avg Forecast$1.71B$1.31B$850.00M$1.01B$1.10B$1.26B$1.38B$1.44B
High Forecast$2.06B$1.57B$1.02B$1.01B$1.10B$1.40B$1.41B$1.47B
Low Forecast$1.37B$1.04B$680.00M$1.00B$1.10B$1.11B$1.21B$1.37B
Surprise %16.48%-27.57%0.47%-13.39%-9.80%---

DGX Forecast FAQ

Is Quest Diagnostics stock a buy?

Quest Diagnostics stock has a consensus rating of Hold, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 18 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Quest Diagnostics is a neutral investment for most analysts.

What is Quest Diagnostics's price target?

Quest Diagnostics's price target, set by 34 Wall Street analysts, averages $256.17 over the next 12 months. The price target range spans from $245 at the low end to $262 at the high end, suggesting a potential 5.18% change from the previous closing price of $243.55.

How does Quest Diagnostics stock forecast compare to its benchmarks?

Quest Diagnostics's stock forecast shows a 5.18% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (1.69%).

What is the breakdown of analyst ratings for Quest Diagnostics over the past three months?

  • October 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.
  • September 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.
  • August 2026: 11.76% Strong Buy, 41.18% Buy, 41.18% Hold, 0% Sell, 5.88% Strong Sell.

What is Quest Diagnostics’s EPS forecast?

Quest Diagnostics's average annual EPS forecast for its fiscal year ending in December 2026 is $10.51, marking a 18.49% increase from the reported $8.87 in 2025. Estimates for the following years are $11.56 in 2027, and $12.71 in 2028.

What is Quest Diagnostics’s revenue forecast?

Quest Diagnostics's average annual revenue forecast for its fiscal year ending in December 2026 is $11.13B, reflecting a 0.87% increase from the reported $11.04B in 2025. The forecast for 2027 is $11.68B, and $12.06B for 2028.

What is Quest Diagnostics’s net income forecast?

Quest Diagnostics's net income forecast for the fiscal year ending in December 2026 stands at $1.26B, representing an 26.63% increase from the reported $992M in 2025. Projections indicate $1.38B in 2027, and $1.44B in 2028.